Crestline Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,500
Closed -$725K 338
2021
Q4
$725K Hold
2,500
0.05% 150
2021
Q3
$726K Buy
+2,500
New +$726K 0.07% 140

Other funds holding XAGE

Crestline Management's XAGE Position: Q1 2022 in Review

Crestline Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2022, closing a stake of 2,500 shares — an estimated $725K sold.

Crestline Management first reported a position in XAGE in Q3 2021 and held it in 2 quarters. The position peaked at $726K in Q3 2021. 27 funds tracked by Wall St. Rank hold XAGE as of Q1 2022.

  • Crestline Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 2,500 Longevity Health Holdings, Inc. Common Stock shares in Q1 2022, an estimated $725K.
  • Crestline Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Crestline Management's Longevity Health Holdings, Inc. Common Stock position peaked at $726K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.